NR5A2 and type 1 diabetes mellitus: We have previously demonstrated that the pharmacological activation of LRH-1/NR5A2 using BL001 promoted immune tolerance and enhance islet cell survival in the RIP-B7.1 and NOD mouse models of T1D (11).